Skip to content

Tag

COVID-19 antivirals

,

What’s the latest on COVID antiviral drugs, and who is eligible in Australia?

Gold Cross | December 5, 2023
Pharmacist Only
,

Pfizer’s COVID-19 oral anti-viral available to more Australians on the Pharmaceutical Benefits Scheme from 1 July

Gold Cross | July 3, 2023
Pharmacist Only
, , ,

Pfizer’s COVID-19 oral anti-viral available to more Australians on the Pharmaceutical Benefits Scheme from 1 April

Gold Cross | March 31, 2023
Pharmacist Only
, ,

Broad spectrum antiviral, pegylated interferon lambda, found to be highly effective for early treatment of COVID-19 across dominant variants

Gold Cross | February 10, 2023
, ,

COVID-19 antivirals must be made available from community pharmacies

Gold Cross | August 11, 2022

Latest Posts

Pharmacist Only
Medical professionals fear cases of B6 toxicity are under-reported
Gold Cross | January 28, 2025
What’s the difference between a food allergy and an intolerance?
Gold Cross | January 28, 2025
Pharmacist Only
Just a couple of days left to save with APP2025 Early Bird pricing!
Gold Cross | January 24, 2025

Featured Posts

Nurturing brain health for business owners
Gold Cross | January 28, 2025
How genuine conversations impact high performing teams
Gold Cross | December 10, 2024
Protecting your pharmacy: online reviews and defamation explained
Gold Cross | December 3, 2024

Tags

Scroll To Top